nach oben

International Journal of Health Economics and Management

07.03.2024 | Research article

How to increase acceptance of the COVID-19 vaccine among poor people in Africa?

verfasst von: Mathieu Juliot Mpabe Bodjongo

Erschienen in: International Journal of Health Economics and Management

Einloggen, um Zugang zu erhalten

Abstract

This study aims to analyze whether good government management of the COVID-19 pandemic can increase the likelihood of vaccine uptake among poor people in Africa. The analysis is based on a sample of 18,010 people living in 34 African countries, drawn from data collected by Afrobarometer (Merged Round 8 data (34 countries), database, 2022). The econometric results, obtained using a bivariate probit regression, show that poverty significantly reduces the odds of accepting the said COVID-19 vaccine. However, acceptance of the vaccine increases among poor individuals when there is (i) trust in the government's published statistics on COVID-19, (ii) control of corruption by the government in managing the pandemic, (iii) individual confidence in the government's ability to ensure the safety of the COVID-19 vaccine, and (iv) belief that the Covid 19 vaccine will be more effective than religious prayer in the fight against this pandemic.

Nur mit Berechtigung zugänglich

UN: United Nations.

Ilostat (2022).

According to Afrobarometer (2022), about 44.16% of Africans have experienced confinement.

WHO: World Health Organization.

Rizk (2022).

See Table 4 in Annex.

Estimate based on World Bank (2022).

They allow for a significant reduction in the costs of a study, the time required and the risk of error. They also facilitate the collection of data in large geographical areas and open up new methodological perspectives (Frippiat & Marquis, 2010; Jean, 2015).

CDD: Center for Democratic Development.

IDASA: Institute for Democracy in South Africa.

MSU: Michigan State University.

Cited by UNICEF (2022)

The variable to be explained and the explanatory variable.

Read (Lollivier, 2001).

See Brunet & Havet (2009)

Abebe, H., Shitu, S., & Mose, A. (2021). Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infection and Drug Resistance, 14, 2015–2025. https://doi.org/10.2147/IDR.S312116CrossRefPubMedCentralPubMed

Acheampong, T., Akorsikumah, E. A., Osae-Kwapong, J., Khalid, M., Appiah, A., & Amuasi, J. H. (2021). Examining vaccine hesitancy in Sub-Saharan Africa: A survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines, 9, 814. https://doi.org/10.3390/vaccines9080814CrossRefPubMedCentralPubMed

Afrobarometer. (2022). Merged Round 8 data (34 countries), database.

Alhassan, R. K., Aberese-Ako, M., Doegah, P. T., Immurana, M., Ayindenaba Dalaba, M., Kwesi-Manyeh, A., Klu, D., Acquah, E., Korkor Ansah, E., & Gyapong, M. (2021). COVID-19 vaccine hesitancy among the adult population in Ghana: Evidence from a pre-vaccination rollout survey. Tropical Medicine and Health, 49, 96. https://doi.org/10.1186/s41182-021-00357-5CrossRefPubMedCentralPubMed

Ali, K. J., & Noman, A. (2013). Determinants of demand for health care in Bangladesh: An econometric analysis. World Journal of Social Sciences, 3(6), 153–163.

Allington, D., McAndrew, S., Moxham-Hall, V., & Duffy, B. (2023). Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic. Psychological Medicine, 53, 236–247. https://doi.org/10.1017/S0033291721001434CrossRefPubMed

Badré, B. (2020). Le développement durable après la crise de la COVID-19. Revue D’économie Financière, 139–140(3–4), 211–218.

Bangalee, A., & Bangalee, V. (2021). Fake news and fallacies: Exploring vaccine hesitancy in South Africa. South African Family Practice, 63(1), a5345. https://doi.org/10.4102/safpCrossRef

Bargelès, C. (2022). Afrique du Sud: la lutte contre le COVID entachée de corruption, RFI, 26 January 2022 edition, https://www.rfi.fr/fr/afrique/20220126-afrique-du-sud-la-lutte-contre-le-COVID-entachée-de-corruption

Becerra, M. B., & Becerra, B. J. (2022). COVID-19 vaccine hesitancy among behavioral risk takers. Vaccines, 10, 767. https://doi.org/10.3390/vaccines10050767CrossRefPubMedCentralPubMed

Brunet, C., & Havet, N. (2009). Propriété Immobilière et Déqualification dans l’Emploi. Revue D’économie Française, 24(1), 121–155.CrossRef

Burggraf, C., Glauben, T., & Grecksch, W. (2016). New impacts of Grossman’s health investment model and the Russian demand for medical care. Journal of Public Health, 24, 41–56. https://doi.org/10.1007/s10389-015-0692-5CrossRef

CDC Africa. (2021). COVID-19 vaccine perceptions: A 15-country study. African Union Working Paper, 71.

Callaghan, T., Moghtaderi, A., Lueck, J. A., Hotez, P., Strych, U., Dor, A., Fowler, E. F., & Motta, M. (2021). Correlates and disparities of intention to vaccinate against COVID-19. Social Science & Medicine, 272, 113638. https://doi.org/10.1016/j.socscimed.2020.113638CrossRef

Carcelen, A. C., Prosperi, C., Mutembo, S., Chongwe, G., Mwansa, F. D., Ndubani, P., Simulundu, E., Chilumba, I., Musukwa, G., Thuma, P., Kapungu, K., Hamahuwa, M., Mutale, I., Winter, A., Moss, W. J., & Truelove, S. (2022). COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa. Human Vaccines & Immunotherapeutics, 18(1), 1–6. https://doi.org/10.1080/21645515.2021.1948784CrossRef

Chinawa, A. T., Chinawa, J. M., Ossai, E. N., Obinna, N., Onukwuli, V., Aronu, A. E., & Manyike, C. P. (2021). Maternal level of awareness and predictors of willingness to vaccinate children against COVID 19; a multi-center study. Human Vaccine Immunotherapeutics, 17(11), 3982–3988. https://doi.org/10.1080/21645515.2021.1963172CrossRef

Chutiyami, M., Salihu, D., Bello, U. M., Winser, S. J., Gambo, A. A., Sabo, H., Kolo, A. M., Jalo, H. A., Muhammad, A. S., Mahmud, F. A., Adeleye, K. K., Azubuike, O. M., Bukola, I. M., Kannan, P. (2022). Are fear of COVID-19 and vaccine hesitancy associated with COVID-19 vaccine uptake? A population-based online survey in Nigeria. Vaccines, 10(8). https://doi.org/10.3390/vaccines10081271

Deml, M. J., & Githaiga, J. N. (2022). Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: A scoping review. British Medical Journal Open, 12, e066615. https://doi.org/10.1136/bmjopen-2022-066615CrossRef

Dereje, N., Tesfaye, A., Tamene, B., Alemeshet, D., Abe, H., Tesfa, N., Gedion, S., Biruk, T., & Lakew, Y. (2022). COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-method study. British Medical Journal Open, 12, e052432. https://doi.org/10.1136/bmjopen-2021-052432CrossRef

Diarra, A., Traore, A. M., Touré, M. K., Traore, B., Kodio, M., Coulibaly, Y. I., Dicko, A. A., & Faye, O. (2021). Profil Épidémioclinique des Patients Infectés par le COVID-19 à l'Hôpital de Dermatologie de Bamako", Health Sciences and Disease, 22(5). Retrieved from https://www.hsd-fmsb.org/index.php/hsd/article/view/2659

Dinga, J. N., Sinda, L. K., & Titanji, V. P. K. (2021). Assessment of vaccine hesitancy to a COVID-19 vaccine in cameroonian adults and its global implication. Vaccines, 9, 175. https://doi.org/10.3390/vaccines9020175CrossRefPubMedCentralPubMed

Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020). Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology, 35, 775–779. https://doi.org/10.1007/s10654-020-00671-yCrossRefPubMedCentralPubMed

Faly Ba, M., Adama Faye, Kane, B., Diallo, A. I., Junot, A., Gaye, I., Bonnet, E., & Ridde, V. (2022). Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study. Human Vaccines & Immunotherapeutics, 18:5. https://doi.org/10.1080/21645515.2022.2060020.

Faye, S. L., Krumkamp, R., Doumbia, S., Tounkara, M., Strauss, R., Ouedraogo, H. G., Sagna, T., Barry, A. M., Mbawah, A. K., Doumbia, C. O., Diouf, S., Cisse, K., Harding, M., Donven, P., & May, J., Puradiredja, D. I., & Fusco, D. (2022). Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: A cross-sectional study. BMJ Open, 12(4). https://doi.org/10.1136/bmjopen-2021-059138

Frippiat, D., & Marquis, N. (2010). Les enquêtes par Internet en sciences sociales : Un état des lieux. Population, 65(2), 309–338. https://doi.org/10.3917/popu.1002.0309CrossRef

Gaitonde, R., Oxman, A. D., Okebukola, P. O., & Rada, G. (2016). Interventions to reduce corruption in the health sector. Cochrane Database of Systematic Reviews, Issue 8. Art. No.: CD008856. https://doi.org/10.1002/14651858.CD008856.pub2

Gbeasor-Komlanvi, F. A., Afanvi, K. A., Konu, Y. R., Agbobli, Y., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., Nayo-Apetsianyi, J., Agoro, S., Lambokale, A., Nyametso, D., N'tapi, T., Aflagah, K., Mijiyawa, M., & Ekouevi, D. K. (2021). Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo. Public Health in Practice, 2, https://doi.org/10.1016/j.puhip.2021.100220

George, G., Nota, P. B., Strauss, M., Lansdell, E., Peters, R., Brysiewicz, P., Nadesan-Reddy, N., Wassenaar, D. (2023). Understanding COVID-19 vaccine hesitancy among healthcare workers in South Africa. Vaccines, 11, 414. https://doi.org/10.3390/vaccines11020414

Gerdtham, U. G., Søgaard, J., Andersson, F., & Bengt Jönsson, B. (1992). An econometric analysis of health care expenditure: A cross-section study of the OECD countries. Journal of Health Economics, 11(1), 63–84. https://doi.org/10.1016/0167-6296(92)90025-VCrossRefPubMed

Grossman, M. (1972). On the concept of health capital and the demand for health. Journal of Political Economy, 80(2), 223–255.CrossRef

Grossman, M. (1975). Joint production in the household. miméo, NBER et New York City University.

Hitiris, T., & Posnett, J. (1992). The determinants and effects of health expenditure in developed countries. Journal of Health Economics, 11(2), 173–181. https://doi.org/10.1016/0167-6296(92)90033-WCrossRefPubMed

Hsieh, C. R., & Lin, S. J. (1997). Health information and the demand for preventive care among the elderly in Taiwan. The Journal of Human Resources, 32(2), 308–333. https://doi.org/10.2307/146217CrossRef

ILOSTAT. (2022). Statistics on working poverty. ILO database. https://ilostat.ilo.org/topics/working-poverty/

Jacquemot, P. (2020). Les systems de santé en Afrique mis à l’épreuve. Policy Center for the New South, Policy Brief n° PB20-32, 14p.

Jean, É. (2015). Issues related to online data collection: The case of a research with managers. La Revue Des Sciences De Gestion, 272(2), 13–21. https://doi.org/10.3917/rsg.272.0013CrossRef

Kahn, F., Bonander, C., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Inghammar, M., & Björk, J. (2022). Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022. Euro Surveillance, 27(9). https://doi.org/10.2807/1560-7917.ES.2022.27.9.2200121

Kanyanda, S., Markhof, Y., Wollburg, P., & Zezza, A. (2021). Acceptance of COVID-19 vaccines in sub-Saharan Africa: Evidence from six national phone surveys. British Medical Journal Open. https://doi.org/10.1136/bmjopen-2021-055159CrossRef

Kassa Mekonnen, C, Gizaw Demissie, N, Wako Beko, Z, Mulu Ferede, Y, Kindie Abate, H., (2022). Intent to get vaccinated against COVID-19 pandemic and its associated factors among adults with a chronic medical condition. International Journal of African Nursing Science, 16. https://doi.org/10.1016/j.ijans.2022.100401

Kenkel, D. (1994). The demand for preventive medical care. Applied Economics, 26(4), 313–325.CrossRef

Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 vaccination hesitancy in the United States: A rapid national assessment. Journal of Community Health, 46, 270–277. https://doi.org/10.1007/s10900-020-00958-xCrossRefPubMedCentralPubMed

Lachkar, M. (2021). COVID-19: Les faiblesses statistiques de certains pays africains empêchent une évaluation fiable de l'épidémie", Franceinfo of 16 June 2021, https://www.francetvinfo.fr/monde/afrique/societe-africaine/COVID-19-les-faiblesses-statistiques-de-certains-pays-africains-empechent-une-evaluation-fiable-de-l-epidemie_4664495.html

Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K., Ratzan, S. C., Parsons Leigh, J., Hu, J., & El-Mohandes, A., (2022). Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nature Communication, 13, 3801, https://doi.org/10.1038/s41467-022-31441-x

Leye, M., Keita, I., & Bassoum, O. (2020). Connaissances, attitudes et pratiques de la population de la région de Dakar sur la COVID-19. Santé Publique, 32(5–6), 549–561. https://doi.org/10.3917/spub.205.0549CrossRefPubMed

Lollivier, S. (2002). Endogeneity in a system of Normal Bivariate equations with Qualitative Variables, paper presented in 2002 at a symposium organised by INSEE on the theme "Actes des Journées de Méthodologie Statistique", 11.

Lollivier, S. (2001). Endogeneity of a dichotomous explanatory variable in the framework of a bivariate probit model: An application to the link between fertility and female activity. Annals of Economics and Statistics, 62, 251–269.

Lucia, V. C., Kelekar, A., & Afonso, N. M. (2021). COVID-19 vaccine hesitancy among medical students. Journal of Public Health, 43(3), 445–449. https://doi.org/10.1093/pubmed/fdaa230CrossRefPubMed

MacDonald, N. E. (2015). SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33, 4161–4164. https://doi.org/10.1016/j.vaccine.2015.04.036CrossRefPubMed

Makooi, B., & May, A. (2021). COVID-19 in Africa: The situation of access to vaccines has become practically untenable, France 24, edition of 12 April 2021, https://www.france24.com/fr/afrique/20210412-COVID-19-en-afrique-la-situation-de-l-accès-aux-vaccins-est-devenue-pratiquement-intenable

Di Matteo, L., & Di Matteo, R. (1998). Evidence on the determinants of Canadian provincial government health expenditures: 1965–1991. Journal of Health Economics, 17(2), 211–228. https://doi.org/10.1016/S0167-6296(97)00020-9CrossRefPubMed

McElfish, P. A., Willis, D. E., Shah, S. K., Bryant-Moore, K., Rojo, M. O., & Selig, J. P. (2021). Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy. Journal of Primary Care & Community Health, 12, 1–7. https://doi.org/10.1177/21501327211040746CrossRef

Mocan, N. H., Tekin, E., & Zax, J. S. (2004). The demand for medical care in urban China. World Development, 32(2), 289–304.CrossRef

Mose, A., Wasie, A., Shitu, S., Haile, K., Timerga, A., Melis, T., Sahle, T., & Zewdie, A. (2022). Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis. PLoS ONE, 17, 1–15. https://doi.org/10.1371/journal.pone.0269273CrossRef

Mpabe, B. M. J. (2021). Pauvreté, croyances sur la transmission du VIH-SIDA et écart du dépistage du VIH-SIDA chez les femmes entre zones rurales et urbaines au Cameroun. Journal De Gestion Et D’économie De La Santé, 39(3–4), 158–182.

Ngoy Mutombo, P., Fallah, M. P., Munodawafa, D., Kabel, A., Houeto, D., Goronga, T., Mweemba, O., Balance, G., Onya, H., Kamba, R. S., Chipimo, M., Ntumba Kayembe, J. M., Akanmor, B., (2022). COVID-19 vaccine hesitancy in Africa: A call to action. The LancetGlobal Health, 10(3), pp. 320–321.

Orangi, S., Pinchoff, J., Mwanga, D., Abuya, T., Hamaluba, M., Warimwe, G., Austrian, K., & Barasa, E. (2021). Assessing the level and determinants of COVID-19 vaccine confidence in Kenya. Vaccines, 9(8), 936. https://doi.org/10.3390/vaccines9080936CrossRefPubMedCentralPubMed

Osuagwu, U. L., Mashige, K. P., Ovenseri-Ogbomo, G., Awazzi Envuladu, E., Kwasi Abu, E., Asabe Miner, C., Timothy, C. G., Ekpenyong, B. N., Langsi, R., Amiebenomo, O. M., Oloruntoba, R., Goson, P. C., Charwe, D., Ishaya, T., Agho, K. E. (2023). The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa. BMC Public Health, 23, 38. https://doi.org/10.1186/s12889-022-14972-2

Pallegedara, A., & Grimm, M. (2017). Demand for private healthcare in a universal public healthcare system: Empirical evidence from Sri Lanka. Health Policy and Planning, 32(9), 1267–1284. https://doi.org/10.1093/heapol/czx085CrossRefPubMed

Prata Menezes, N., Simuzingili, M., Debebe, Z. Y., Pivodic, F., & Massiah, E. (2021). Understanding the disincentives to COVID-19 vaccination in sub-Saharan Africa. World Bank Blog, Africa Can End Poverty, https://blogs.worldbank.org/fr/africacan/comprendre-les-freins-la-vaccination-contre-la-COVID-19-en-afrique-subsaharienne

Razai, M. S., Osama, T., McKechnie, D. G. J., & Majeed, A. (2021). Covid-19 vaccine hesitancy among ethnic minority groups. BMJ, 372(513), https://doi.org/10.1136/bmj.n513.

Rizk, Y. (2022). .COVID-19: who wants 300 million vaccines?. Jeune Afrique, 23 February 2022 edition, https://www.jeuneafrique.com/1317617/economie/COVID-19-qui-veut-300-millions-de-vaccins/

Sallam, M. (2021). COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines, 9(2). https://doi.org/10.3390/vaccines9020160

Sambira, J. (2013). Counterfeit medicines: a health problem in Africa, Africa Renewal, May 2013 edition, https://www.un.org/africarenewal/fr/magazine/mai-2013/médicaments-contrefaits-un-problème-de-santé-en-afrique

Sato, R. (2022). COVID-19 vaccine hesitancy and trust in Government in Nigeria. Vaccines, 10, 1008. https://doi.org/10.3390/vaccines10071008CrossRefPubMedCentralPubMed

Sauerborn, R., Nougtara, A., & Latimer, E. (1994). The elasticity of demand for health care in Burkina Faso: Differences across age and income groups. Health Policy and Planning, 9(2), 185–192. https://doi.org/10.1093/heapol/9.2.185CrossRefPubMed

Savadogo M., Ouattara, A., Dahani, C. K., Nikiéma, O., Traoré, S., Nagréongo, B., Savadogo, N. (2021). Profil épidémiologique et clinique des cas suspects de COVID-19 reçus au CHU Yalgado Ouédraogo du Burkina Faso. Revue malienne d'infectiologie et microbiologique, 16 (1), pp. 7–10.

Seydou, A. (2021). Who wants COVID-19 vaccination? In 5 West African countries, hesitancy is high, trust low. Afrobarometer Dispatch, No. 432, 13

Skordis-Worrall, J., Pace, N., Bapat, U., Das, S., More, N. S., Joshi, W., Pulkki-Brannstrom, A., M., & Osrin, D. (2011). Maternal and neonatal health expenditure in mumbai slums (India): A cross sectional study. BMC Public Health, 11(150). https://doi.org/10.1186/1471-2458-11-150

Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021). Factors associated with COVID-19 vaccine hesitancy. Vaccines, 9(300). https://doi.org/10.3390/vaccines9030300

Sulemane, N., Armocida, B., Valente, M., Formenti, B., Barigazzi, S., Ussai, S., Monasta, L., Castelli, F., Missoni, E. (2022). Vaccines hesitancy in Africa: how COVID-19 pandemic may affect malaria vaccination campaigns. Journal of Preventive Medical Hygiene, 63(1):E1–E3. https://doi.org/10.15167/2421-4248/jpmh2022.63.1.2420

Troiano, G., & Nardi, A. (2021). Vaccine hesitancy in the era of COVID-19. Public Health, 194, 245–251. https://doi.org/10.1016/j.puhe.2021.02.025CrossRefPubMed

UN. (2021). Report on the Sustainable Development Goals 2021", UN working paper, 68p.

UNICEF (2022). What you need to know about COVID-19 vaccines. UNICEF working paper, https://www.unicef.org/fr/recits/tout-ce-que-vous-devez-savoir-sur-le-vaccin-contre-la-COVID-19

WHO. (2018). State of health in the WHO African Region: analysis of health status, services and systems in the context of the Sustainable Development Goals. WHO Regional Office for Africa Working Paper, Brazzaville.

WHO. (2021). Risks and challenges of rolling out COVID-19 vaccines in Africa. WHO Working Paper, https://www.afro.who.int/fr/news/risques-et-difficultes-lies-au-deploiement-des-vaccins-contre-la-COVID-19-en-afrique

WHO. (2019). Ten threats to global health in 2019. Available at: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019

Wang, F. (2018). The role of preventive and curative health care in economic development. PLoS ONE, 13(11), 1–12. https://doi.org/10.1371/journal.pone.0206808CrossRef

Wang, D., Chukwu, A., Mwanyika-Sando, M., Watara Abubakari, S., Assefa, N., Madzorera, I., Hemler, E. C., Ismail, A., Lankoande, B., Mapendo, F., Millogo, O., Workneh, F., Azemraw, T., Fawzi, W. W. (2022). COVID-19 vaccine hesitancy and its determinants among sub-Saharan African adolescents. Plos Global Public Health, https://doi.org/10.1371/journal.pgph.0000611

Wiysonge, C. S., Alobwede, S. M., Katoto, P. D. M., Kidzeru, E. B., Lumngwena, E. N., Cooper, S., Goliath, R., Jackson, A., & Shey, M. S., (2022). COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa. Expert Review of Vaccines, 21(4), 549–559, https://doi.org/10.1080/14760584.2022.2023355.

World Bank (2022). World development indicator, World Bank Database.

Yendewa, S. A., Ghazzawi, M., James, P. B., Smith, M., Massaquoi, S. P., Babawo, L. S., Deen, G. F., Russell, J. B. W., Samai, M., Sahr, F., Lakoh, S., Salata, R. A., & Yendewa, G. A. (2022). COVID-19 vaccine hesitancy among healthcare workers and trainees in freetown, Sierra Leone: A cross-sectional study. Vaccines, 10(757) https://doi.org/10.3390/vaccines10050757

Yilma, D., Mohammed, R., Abdela, S. G., Enbiale, W., Seifu, F., Pareyn, M., Liesenborghs, L., Van Griensven, J., Van Henten, S. (2022). COVID-19 vaccine acceptability among healthcare workers in Ethiopia: do we practise what we preach?. Tropical Medicine and International Health, 27(4), 418–425. https://doi.org/10.1111/tmi.13742.

Zhou, Z., Su, Y., Gao, J., Xu, L., & Zhang, Y. (2011). New estimates of elasticity of demand for healthcare in rural China. Health Policy, 103(2–3), 255–265. https://doi.org/10.1016/j.healthpol.2011.09.005CrossRefPubMed

Titel: How to increase acceptance of the COVID-19 vaccine among poor people in Africa?
verfasst von: Mathieu Juliot Mpabe Bodjongo
Publikationsdatum: 07.03.2024
Verlag: Springer US
Erschienen in: International Journal of Health Economics and Management
Print ISSN: 2199-9023
Elektronische ISSN: 2199-9031
DOI: https://doi.org/10.1007/s10754-024-09370-7

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten